UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 99

Sortiert nach

Patterns of Arterial Disease in Takayasu Arteritis and Giant Cell Arteritis

Arthritis care & research (2010), 2020-11, Vol.72 (11), p.1615-1624

2020

Link zum Volltext

Verfügbarkeit prüfen

Are the 1990 American College of Rheumatology vasculitis classification criteria still valid?

Rheumatology (Oxford, England), 2017-07, Vol.56 (7), p.1154-1161

2017

Link zum Volltext

Verfügbarkeit prüfen

Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire

Annals of the rheumatic diseases, 2018-08, Vol.77 (8), p.1157

2018

Link zum Volltext

Verfügbarkeit prüfen

Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines

Rheumatology (Oxford, England), 2020-04, Vol.59 (4), p.e24-e32

2020

Link zum Volltext

Verfügbarkeit prüfen

Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016

Journal of rheumatology, 2017-12, Vol.44 (12), p.1933

2017

Link zum Volltext

Verfügbarkeit prüfen

Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018

Journal of rheumatology, 2019-09, Vol.46 (9), p.1198

2019

Link zum Volltext

Verfügbarkeit prüfen

Association of the AAV-PRO questionnaire with established outcome measures in AAV

Rheumatology (Oxford, England), 2024-01, Vol.63 (1), p.174-180

2024

Link zum Volltext

Verfügbarkeit prüfen

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK

Annals of the rheumatic diseases, 2015-01, Vol.74 (1), p.129-135

2015

Link zum Volltext

Verfügbarkeit prüfen

Systemic vasculitis and patient-reported outcomes: how the assessment of patient preferences and perspectives could improve outcomes

Patient related outcome measures, 2019-01, Vol.10, p.37-42

2019

Link zum Volltext

Verfügbarkeit prüfen

Patient-reported outcomes in vasculitis

Best practice & research. Clinical rheumatology, 2023-03, Vol.37 (1), p.101829-101829, Article 101829

2023

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic Assessment Strategies and Disease Subsets in Giant Cell Arteritis: Data From an International Observational Cohort

Arthritis & rheumatology (Hoboken, N.J.), 2020-04, Vol.72 (4), p.667-676

2020

Link zum Volltext

Verfügbarkeit prüfen

Validation of a patient-reported outcome measure for giant cell arteritis

Rheumatology (Oxford, England), 2024-01, Vol.63 (1), p.181-189

2024

Link zum Volltext

Verfügbarkeit prüfen

Patient perceptions of health-related quality of life in giant cell arteritis: international development of a disease-specific patient-reported outcome measure

Rheumatology (Oxford, England), 2021-10, Vol.60 (10), p.4671-4680

2021

Link zum Volltext

Verfügbarkeit prüfen

Assessing glucocorticoid toxicity: are the measures sensitive enough?

The Lancet. Rheumatology, 2023-03, Vol.5 (3), p.e113-e114

2023

Link zum Volltext

Verfügbarkeit prüfen

Validation of a new glucocorticoid-specific Patient-Reported Outcome Questionnaire (the Steroid PRO)

Annals of the rheumatic diseases, 2023-11, Vol.83 (3), p.394

2023

Link zum Volltext

Verfügbarkeit prüfen

Response to: Correspondence on '2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis' by Joanna C Robson et al and '2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis' by Pimentel-Quiroz et al

Annals of the rheumatic diseases, 2023-08, Vol.82 (8), p.e198

2023

Link zum Volltext

Verfügbarkeit prüfen

Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases

Seminars in arthritis and rheumatism, 2024-02, Vol.64, p.152338-152338, Article 152338

2024

Link zum Volltext

Verfügbarkeit prüfen

Health professionals' perspectives on psychological distress and meeting patients' support needs in rheumatology care settings: A qualitative study

Musculoskeletal care, 2023-06, Vol.21 (2), p.537-544

2023

Link zum Volltext

Verfügbarkeit prüfen

Which Patients with Giant Cell Arteritis Will Develop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Research Datalink Study

Journal of rheumatology, 2016-06, Vol.43 (6), p.1085

2016

Link zum Volltext

Verfügbarkeit prüfen

ANCA Associated Vasculitis Subtypes: Recent Insights and Future Perspectives

Journal of inflammation research, 2022-01, Vol.15, p.2567-2582

2022

Link zum Volltext

Verfügbarkeit prüfen

The patient perspective of nurse‐led care in early rheumatoid arthritis: A systematic review of qualitative studies with thematic analysis

Journal of clinical nursing, 2021-01, Vol.30 (1-2), p.145-160

2021

Link zum Volltext

Verfügbarkeit prüfen

Comment on: Benchmarking tocilizumab use for giant cell arteritis

Rheumatology advances in practice, 2022-12, Vol.6 (3), p.rkac069-rkac069

2022

Link zum Volltext

Verfügbarkeit prüfen

The patient's perspective of the adverse effects of glucocorticoid use: A systematic review of quantitative and qualitative studies. From an OMERACT working group

Seminars in arthritis and rheumatism, 2020-10, Vol.50 (5), p.996-1005

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(83)

Publikationsform

Artikel
(98)
Buchkapitel
(1)

Sprache

Englisch
(99)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Patterns of Arterial Disease in Takayasu Arteritis and Giant Cell Arteritis

Are the 1990 American College of Rheumatology vasculitis classification criteria still valid?

Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire

Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines

Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016

Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018

Association of the AAV-PRO questionnaire with established outcome measures in AAV

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK

Systemic vasculitis and patient-reported outcomes: how the assessment of patient preferences and perspectives could improve outcomes

Patient-reported outcomes in vasculitis

Diagnostic Assessment Strategies and Disease Subsets in Giant Cell Arteritis: Data From an International Observational Cohort

Validation of a patient-reported outcome measure for giant cell arteritis

Patient perceptions of health-related quality of life in giant cell arteritis: international development of a disease-specific patient-reported outcome measure

Assessing glucocorticoid toxicity: are the measures sensitive enough?

Validation of a new glucocorticoid-specific Patient-Reported Outcome Questionnaire (the Steroid PRO)

Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: international development of a glucocorticoid treatment–specific patient-reported outcome measure

Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases

Health professionals' perspectives on psychological distress and meeting patients' support needs in rheumatology care settings: A qualitative study

Which Patients with Giant Cell Arteritis Will Develop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Research Datalink Study

ANCA Associated Vasculitis Subtypes: Recent Insights and Future Perspectives

The patient perspective of nurse‐led care in early rheumatoid arthritis: A systematic review of qualitative studies with thematic analysis

Comment on: Benchmarking tocilizumab use for giant cell arteritis

The patient's perspective of the adverse effects of glucocorticoid use: A systematic review of quantitative and qualitative studies. From an OMERACT working group

Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study

Suchergebnisse filtern